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Mesencephalic astrocyte derived neurotrophic factor (MANF) is recognized as a dopaminergic neurotrophic
factor, which can protect dopaminergic neurons from neurotoxic damage. However, little is known about
the function of MANF during the vertebrate development. Here, we report that MANF expression is
widespread during embryonic development and in adult organs analyzed by qPCR and in situ hybridization
in zebraﬁsh. Knockdown of MANF expression with antisense splice-blocking morpholino oligonucleotides
resulted in no apparent abnormal phenotype. Nevertheless, the dopamine level of MANF morphants was
lower than that of the wild type larvae, the expression levels of the two tyrosine hydroxylase gene
transcripts were decreased and a decrease in neuron number in certain groups of th1 and th2 cells in the
diencephalon region in MANF morphants was observed. These defects were rescued by injection of
exogenous manf mRNA. Strikingly, manf mRNA could partly restore the decrease of th1 positive cells in
Nr4a2-deﬁcient larvae. These results suggest that MANF is involved in the regulation of the development of
dopaminergic system in zebraﬁsh.
& 2012 Elsevier Inc. All rights reserved.Introduction
Parkinson’s disease (PD) is a progressive neurodegenerative dis-
order. The hallmark symptoms of PD, resting tremor, rigidity, and
bradykinesia, result from loss of dopaminergic neurons in the sub-
stantia nigra pars compacta and the ascending innervations of the
striatum, leading to depletion of dopamine (Dauer and Przedborski,
2003). L-3,4-dihydroxyphenylalanine (L-dopa) is the most widely
used therapy for PD. However, after long-term treatment, it becomes
less effective and causes various side effects such as dystonia and
dyskinesia. Alternatively, discovering how to improve the PD symp-
toms by enhancing the survival of the remaining dopaminergic
neurons to increase availability of dopamine in the striatum may
become a potential treatment. Lately, a novel evolutionarily con-
served neurotrophic factor family including cerebral dopamine neu-
rotrophic factor (CDNF) and mesencephalic astrocyte-derived
neurotrophic factor (MANF) has emerged as potentially useful target
(Lindholm et al., 2008; Lindholm and Saarma, 2010; Lindholm et al.,
2007; Petrova et al., 2004; Yasuda and Mochizuki, 2010).
MANF, a 20 kDa secreted protein, was primarily found to have
selectively protective function on nigral dopaminergic neurons,
but not GABAergic or serotonergic neurons in ventral mesence-
phalic cell cultures from embryonic rat brains (Petrova et al.,
2003). In rodent brains, relatively high manf mRNA levels arell rights reserved.
te of Biomedicine/Anatomy,
0014 Finland.
la).detected in the cerebral cortex, hippocampus and cerebellum; in
non-neuronal mouse tissues, it can be detected in the liver,
kidney and testes (Lindholm et al., 2008). In the 6-hydro-
xydopamine (6-OHDA) rat model of PD, following an intrastriatal
injection of MANF, nigrostriatal dopaminergic neurons are pro-
tected from degeneration and the dopaminergic function in the
striatum can be restored (Voutilainen et al., 2009). Furthermore,
MANF transcripts and protein levels are increased after ischemic
and epileptic insults in the cerebral cortex, suggesting that MANF
may have neuroprotective effects against neurotoxins and cere-
bral ischemia (Lindholm et al., 2008; Voutilainen et al., 2009; Yu
et al., 2010). The crystal structure of mammalian MANF has
revealed that the amino-terminal region of MANF family mem-
bers contains a saposin-like domain which may interact with
lipids and membranes whereas the carboxy-terminal region
includes an intradomain cysteine bridge in a CXXC motif which
may protect cells from endoplasmic reticulum stress induced
apoptosis (Hellman et al., 2010; Hoseki et al., 2010; Parkash et al.,
2009). MANF is also found in invertebrates; for instance, Droso-
phila MANF is expressed in glia and neurons, and knocking out
manf expression leads to neuronal degeneration causing embryo-
nic lethality, indicating that MANF is required for the mainte-
nance of neural cells in the ﬂy (Palgi et al., 2009). In vertebrates,
several factors, such as pax2/5, Lmx1a, Nr4a2 and pitx3, have
been identiﬁed to play crucial roles in determination of the
developmental fate of midbrain dopaminergic neurons (Andressoo
and Saarma, 2008; Simon et al., 2003). Nonetheless, it is currently
not known if MANF is involved in development of dopaminergic
neurons.
Y.-C. Chen et al. / Developmental Biology 370 (2012) 237–249238Zebraﬁsh is increasingly used as a vertebrate animal model,
also in studies on neurodegenerative diseases such as Parkinson’s
disease, Alzheimer’s disease and Huntington’s disease due to a
short generation time, external development, and the high simi-
larity of neuroanatomy and circuit formation between the zebra-
ﬁsh CNS and mammalian brain (Bandmann and Burton, 2010;
Panula et al., 2010). In the vertebrate nervous system, MANF is
mainly known due to its neuroprotective functions (Airavaara
et al., 2009; Voutilainen et al., 2009; Yu et al., 2010). In this study,
we used antisense morpholino oligonucleotides to reduce MANF
protein expression and analyzed the effect on catecholaminergic,
serotonergic, orexinergic and histaminergic systems to character-
ize the biological role of MANF in developing zebraﬁsh brains.Materials and methods
Zebraﬁsh strain and maintenance
Zebraﬁsh were obtained from our breeding line maintained in
the laboratory for more than 10 years (Kaslin et al., 2004; Kaslin
and Panula, 2001; Sallinen et al., 2009a; Sallinen et al., 2009b).
Developing embryos were staged in hours post-fertilization (hpf)
or days post-fertilization (dpf) as described previously (Kimmel
et al., 1995). Embryos and larvae were raised at 28 1C. For in situ
hybridization, embryos less than 3 dpf of age were treated with
0.03% phenylthiourea added in E3 medium (5 mM NaCl, 0.17 mM
KCl, 0.4 mM CaCl2, and 0.16 mM MgSO4) to inhibit pigmentation.
The permits for the experiments were obtained from the Ofﬁce of
the Regional Government of Southern Finland in agreement with
the ethical guidelines of the European convention.
RNA isolation and cDNA synthesis
Total RNA was extracted using RNeasy mini Kit (Qiagen Inc.,
Valencia, CA) according to the instructions of the manufacturer.
For the developmental expression analysis and morpholino oli-
gonucleotide efﬁcacy assay, 30-pooled embryos were collected at
certain stages. For tissue-speciﬁc expression study, brain, eye,
liver and kidney tissues were collected from ﬁve individual one-
year-old male zebraﬁsh. Two microgram of total RNA was
reverse-transcribed using SuperScriptTM III reverse transcriptase
(Invitrogen, USA) according to the manufacturer’s instruction.
Quantitative real-time PCR (qPCR)
qPCR was performed on the SmartCycler II instrument (Cepheid,-
Sunnyvale, CA) using the SYBRsPremix Ex TaqTM (TAKARA BIO,
Tokyo, Japan). Primers for ampliﬁcation were designed by Primer-
BLAST (NCBI) and sequences are shown in Table 1. The primer
sequence of pax2a and pax5 were according to Lin et al., 2009.Table 1
List of primers for the qPCR analysis.










b-actin CGAGCAGGAGATGGGAACC CAACGGAATwo housekeeping genes, b-actin and ribosomal protein L13a (rpl13a),
were used as reference controls. b-actin primers were obtained from
the Real-time PCR Primer Databank (http://medgen.ugent.be/rtpri
merdb/). Cycling parameters were as follows: 95 1C for 30 s and 45
cycles of the following, 95 1C for 10 s and 62 1C for 45 s. Fluorescence
changes were monitored with SYBR Green after every cycle. Dissocia-
tion curve analysis was performed (0.2 1C per s increase from 60 1C to
95 1C with continuous ﬂuorescence readings) at the end of cycles to
ensure that only single amplicon was obtained. All reactions were
performed in duplicates. Results were evaluated with the SmartCycler
II software. The data were calculated by the comparative method
using Ct values of b-actin and rpl13a, respectively, as the reference
control (Livak and Schmittgen, 2001). Since the gene expression
changes showed the same trend when normalized to different
housekeeping genes (data not shown), the results referred to b-actin
are shown in this study.
Morpholino oligonucleotide (MO) design, use and mRNA injections
Three antisense MOs (Gene Tools LLC, Philomath, OR, USA)
were designed to target the 50 untranslated region of MANF (MOt,
50-ATCTGAACGACCACTAATGATACCG30), splicing-donor sites of
exon 2 (MOsp1, 50-GACGGGTACTTACAAATCGGTTTTC-30) and
splicing-donor sites of exon 3 ofMANF (MOsp2,50-TGCAAACAACT-
CACCGTATTTGAGT-30). Nr4a2 MO (50-CATACTGAGCCTGGACGCAG-
GGCAT-30) that targets both 50 untranslated region of Nr4a2a and
Nr4a2b was based on Blin et al., 2008. The working concentration
was determined by injecting serial dilutions of MO. Therefore,
the dose of 8 ng was found to produce the most effective
inhibition without causing any unexpected gross phenotype for
the translation-blocking MO (MOt) and two splice-blocking MOs
(MOsps) morphants. A standard control MO (ctrl MO, 50-CCT CTT
ACC TCA GTT ACA ATT TAT A 30) purchased directly from Gene-
Tools Inc. (Philomath, OR, USA) was injected 8 ng per embryo. To
assess the efﬁcacy of the splice-blocking MOsp, RT-PCR was
performed using primers F1 and F2. In this study, the combination
of two MOsps was co-injected into one-cell stage embryos at the
dose of 4 ng for each MOsp. The MOt injection at the dose of 8 ng
also caused the same effects as MOsps did. The manf full-length
open-reading frame cDNA construct was prepared by RT-PCR
using primers F1 and F2 and Phusion High-Fidelity PCR Master
mix (Finnzymes, Espoo, Finland). The PCR amplicon was cloned
into the pGEM-T Easy vector (Promega, Madison, WT) and veriﬁed
by sequencing. The clone with no mutations was digested with
EcoRI and the insert was cloned into the pMC expression vector
kindly given by Dr. Thomas Czerny (Fink et al., 2006) and linearized
with NotI. Capped sense transcripts from the cDNA expression clone
were generated by the mMESSAGE mMACHINE kit (Ambion, Austin,
TX) using T7 RNA polymerase. For the mRNA rescue experiment,
500 pg of manf mRNA with 8 ng of splice-blocking MOsps were co-










ACGCTCATTGC RTPrimerDB ID:705 qPCR
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Whole-mount in situ hybridization (WISH) was performed on
4% paraformaldehyde (PFA) ﬁxed zebraﬁsh embryos at various
stages less than 5 dpf as described earlier (Chen et al., 2009).
Antisense and sense digoxigenin (DIG)-labeled RNA probes were
generated using the DIG RNA labeling kit (Roche Diagnostics,
Germany), following the instruction of the manufacturer. The
WISH procedure followed Thisse’s protocol (Thisse and Thisse,
2008). The prehybridization and hybridization were conducted at
65 1C for all riboprobes. In situ hybridization signals were
detected with sheep anti-digoxigenin-AP Fab fragments (dilution
1:10,000; Roche Mannheim, Germany). The color staining was
carried out with chromogen substrates (NBT and BCIP) as described
earlier (Chen et al., 2009).Protein extraction and Western blotting
The protocol was modiﬁed based on the zebraﬁsh book
(Westerﬁeld, 2000). The 3-dpf dechorionated embryos were
deyolked in cold Ringer’s solution (116 mM NaCl, 2.9 mM KCl,
1.8 mM CaCl2 and 5.0 mM HEPES, pH 7.2) by triturating with a
glass pipette with a tip diameter approximately the size of the
yolk. The dechorionated, deyolked embryos were transferred and
homogenized in the lysis buffer 100 mM Tris–HCl, pH 8.0, 1 M
NaCl, 2% Trition X-100, 2% bovine serum albumin, 4 mM EDTA,
1 mM Na-orthovanadate and Mini EDTA-free protease inhibitor
cocktail (Roche, Mannheim, Germany). The homogenized lysate
was incubated on ice for 30 min, and centrifuged at the speed of
13,000 rpm for 15 min at 4 1C. The protein concentration of the
supernatants was measured and 15 mg was used for immunoblot-
ting with rabbit polyclonal anti-MANF antibody (4347, 1:2000;
ProSci Inc, Poway, CA) and the same blot was stripped and
incubated with mouse anti-actin antibody (AC-40, 1:1000; Sigma,
St. Louis, MO). To determine the speciﬁcity of the MANF antibody,
an immunizing peptide blocking experiment was performed. The
MANF antibody was incubated with 100 mg per ml of the blocking
MANF peptide (4347P, ProSci Inc, Poway, CA) that corresponds to
the immunogen peptide used for immunization for 2 h at 37 1C.
The neutralized antibody was used side-by-side with the antibody
alone.Immunocytochemistry
Whole-mount immunostaining was performed on 2% PFA or
4% 1-ethyl-3(3-dimethylaminoproply)-carbodiimide (for GABA
staining) ﬁxed zebraﬁsh embryos at the stage less than 3 dpf.
For 5 dpf ﬁxed larvae, brains were dissected to enhance antigen
presentation. Antibody incubations were carried out with 4%
normal goat serum and 1% DMSO in 0.3% Triton X-100/ PBS for
16 h at 4 1C with gentle agitation. Primary antibodies were anti-
acetylated tubulin mouse antibody (T6793, 1:1000; Sigma,
St. Louis, MO), anti-HuC/D mouse antibody (A21271, 1:1000;
Invitrogen, Eugene, USA), anti-MANF rabbit antibody (4347,
1:3000; ProSci Inc, Poway, CA), anti-serotonin rabbit antibody
(S5545, 1:1000; Sigma, St. Louis, MO) anti-tyrosine hydroxylase
monoclonal mouse antibody (MAB318, 1:1000; Chemicon), and
anti-zebraﬁsh GFAP (zrf 1, 1:5000; Zebraﬁsh International
Resource Center, Oregon, USA), and anti-GABA rabbit antibody
(GABA 1H, 1:1000, (Karhunen et al., 1993)) The speciﬁcity of the
TH and serotonin antibodies has been veriﬁed earlier (Kaslin and
Panula, 2001). The following secondary antibodies were applied:
Alexa Fluors 488 or 568 goat anti-mouse or anti-rabbit IgG
(1:1000; Invitrogen, Eugene, OR).BrdU saturation labeling
The protocol was based on Mueller and Wullimann, 2002.
5 dpf larvae were incubated in 10 mM bromodeoxyuridine (BrdU,
Sigma) in E3 medium at 28.5 1C for 14 h. Larvae were sacriﬁced
immediately and ﬁxed in 4% PFA. Fixed samples were washed
with PBDT (1xPBS, 1% DMSO and 0.1% Tween-20) and placed in
100% of methanol for 1 h at 20 1C and rehydrated in a graded
methanol in PBDT, following rehydration, all larvae were digested
with proteinase K in PBDT (10 mg/ml) for 20 min, reﬁxed in 4%
PFA for 20 min, washed three times in PBDT (310 min). To
denature DNA, samples were incubated in 1 N hydrochloric acid
in PBDT for 1 h at room temperature and washed three times
(320 min) in PBDT. Thereafter, samples were incubated in 4%
blocking solution for 1 h at room temperature and in rat anti-
BrdU (ab6326, 1:300; Abcam, Cambridge, MA) 16 h at 4 1C. The
secondary antibodies were applied as described in the immuno-
cytochemistry section.Imaging
Brightﬁeld images were taken with a Leica DM IRB inverted
microscope with a DFC 480 charge-coupled device camera and
z-stacks were processed with Leica Application Suite software
and Corel DRAW X3 software using the multifocus algorithm.
Immunoﬂuorescence samples were examined using a Leica TCS
SP2 AOBS confocal microscope. For excitation, an Argon laser
(488 nm) and green diode laser (561 nm) were used. Emission
was detected at 500–550 nm and 560–620 nm, respectively.
Cross-talk between the channels, and background noise were
eliminated with sequential scanning and frame averaging as
described earlier (Sallinen et al., 2009b). Stacks of images taken
at 0.2–1.2 mm intervals were compiled, and the maximum inten-
sity projection algorithm was used to produce ﬁnal images with
Leica Confocal Software.Quantiﬁcation of dopaminergic neurons
After WISH staining, specimens were mounted in 80% glycerol
and cell numbers were counted using a 20 objective in the
multifocus mode. All experiments were independently repeated
three times.High performance liquid chromatography (HPLC)
At the stage of 5 dpf, 30-pooled larvae were collected and
sonicated in 150 ml of 2% perchloric acid. After centrifugation,
10 ml of supernatant was assessed for dopamine concentration by
HPLC. The detection details are described in Sallinen et al., 2009a,
2009b.Statistical analysis
Data were analyzed by one-way analysis of variance (ANOVA)
with Dunnett’s test. Student’s t-test was performed to determine
signiﬁcant differences in relative expression levels between the
control and morphant group in stage-relative and tissue-speciﬁc
experiments. Data analysis was performed by GraphPad Prism
v.4.1 software (San Diego, CA).
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manf Orthologue gene in zebraﬁsh is highly conserved
MANF is reported as an evolutionarily conserved neurotrophic
factor according to the amino acid identity and phylogenetic
analysis among invertebrate and vertebrate species (Lindholm
et al., 2008). A BLAST search using human MANF amino acid
sequence (NP_006001) only identiﬁed a single zebraﬁsh manf
homologous gene. RT-PCR was performed to obtain the full-open
reading frame of zebraﬁsh manf cDNA and the predicted amino
acid sequence matched exactly the annotated MANF in the
Genebank database. The zebraﬁsh manf gene consists of four
exons on chromosome 22 (NM_001076629) and the exon–intron
boundaries were highly conserved with human MANF gene. The
open reading frame includes 180 amino acids, sharing approxi-
mated 80%, 66% and 60% of amino acid identity with human, ﬂy
and worm MANF, respectively, and eight structurally conserved
cysteine residues were found in zebraﬁsh MANF. Using the
protein homology/analogy recognition engine Phyre (Kelley and
Sternberg, 2009), the predicted secondary structure showed seven
a-helices and the 3D model had the highest similarity to the
human MANF (Hellman et al., 2010). Moreover, the structure of
N-terminus domain was highly similar to the human saposin
D whereas the C-terminus was similar to SAP domain (Hellman
et al., 2011).Fig. 1. Spatiotemporal expression of themanf transcript during zebraﬁsh embryogenesi
in situ hybridization, anterior to the left. (A) lateral view of a 2 hpf embryo, (B) lateral v
one dpf, two dpf and three dpf embryo, (F’) high magniﬁcation view of a posterior neur
group were collected at deﬁned stages. Each experiment was repeated three times usin
one-year old male ﬁsh and analyzed by qPCR. cc, cranial cavity; i, intestine; L, liver; m
arches; pn, posterior neuromast. Scale bar¼100 mm.manf has widespread expression during embryonic development and
in adult organs.
The spatiotemporal expression of manf was analyzed by whole
mount in situ hybridization (WISH), immunohistochemistry and
qPCR. The manf transcript was detectable at 2 hpf (Fig. 1A).
It appeared in the polster (Fig.1B) and notochord (Fig. 1C) at 11
hpf. At 1 dpf, manf was expressed in the head and otic vesicles
(Fig. 1D); at 2 dpf, the expression was mainly detected in
pharyngeal arches but very little in the head (Fig. 1E). At 3 dpf,
it was primarily expressed in peripheral organs such as cranial
cavity, intestine, liver and posterior neuromasts (Fig. 1F and F’).
On the other hand, positive signals were completely abolished
when the sense riboprobe and omission of the antisense probe
were performed as negative control (data not shown). By qPCR
analysis, the manf transcript had the highest expression level in
whole embryos at 2 hpf (Fig. 1G), and then gradually declined at
later stages, indicating that manf mRNA had maternal contribu-
tion during early development. In male adult tissues, the liver had
the highest expression level compared to the brain, eyes, and
kidney (Fig. 1H).
manf Expression is observed in several adult brain regions
In order to characterize the expression pattern of manf in adult
brain, in situ hybridization and immunohistochemistry weres and in adult organs. (A–F)manf expression pattern was revealed by whole-mount
iew of a 11 hpf embryo, (C) dorsal view of a 11 hpf embryo, (D–F) lateral view of a
omast. (G) manf mRNA levels were analyzed by quantitative PCR. Thirty embryos/
g independent RNA isolations. (H) Adult tissues were collected from ﬁve individual
hb, midbrain–hindbrain boundary; nc, notochord; ov, otic vesicles; pa, pharyngeal
Y.-C. Chen et al. / Developmental Biology 370 (2012) 237–249 241performed on sagittal sections of nine-month-old male ﬁsh brain.
manf transcript was most prominently detected in ventral tele-
ncephalic, preoptic, ventral thalamic, pretectal, dorsal thalamic,
and hypothalamic regions (Fig. 2A). MANF protein was mainly
expressed in the dorsal zone of the dorsal telencephalic area, the
ventral nucleus of the ventral telencephalic area, parvocellular
preoptic nucleus, habenula, anterior thalamic nucleus, periven-
tricular gray zone of optic tectum, telencephalic ventricle, corpus
cerebelli and medial longitudinal fascicle (Fig. 2B). The MANF
protein localization mostly correlated well with the mRNAFig. 2. In situ hybridization mRNA analysis and immunocytochemistry of MANF express
section. Expression can be seen in ventral telencephalic, preoptic, ventral thalamic, pre
shows immuoreactivity for MANF protein. Expression is shown in telencephalic, preopti
antibody co-immunostaining with HuC/D antibody in ventral telencephalic (C), dorsal th
zrf-1 in dorsal telencephalon (F), ventral thalamic region (G), and telencephalic ventricl
(J), and in caudal hypothalamus (K). MANF staining is shown in green; HuC/D, zrf-1 an
zone of periventricular hypothalamus. OB: olfactory bulb. PPa: parvocellular preoptic
Vv: ventral nucleus of ventral telencephalic area. Scale bar¼300 mm in (B), 100 mm inexpression pattern, although MANF immunoreactive cells were
additionally detected in optic tectum, cerebellum and rhomben-
cephalic ventricular regions (Fig. 2B). A slight discordance
between mRNA and protein expression patterns was observed.
This may be caused by the difference of protein trafﬁcking in
various brain regions since MANF is a secretory protein or by
posttranscriptional regulation and/or slow protein turnover rate.
To characterize which cell type speciﬁcally expressed MANF, a
general neural marker (HuC/D)(Kim et al., 1996; Mueller and
Wullimann, 2002) a dopaminergic neuron marker (TH1, tyrosineion in adult zebraﬁsh brain. (A) A sagittal view shows manfmRNA in an adult brain
tectal, dorsal thalamic, and hypothalamic regions. (B) A sagittal view of the brain
c, thalamic, optic tectal, cerebellar and rhombencephalic ventricular regions. MANF
alamic (D), and rhombencephalic ventricular regions (E). Co-immunostaining with
e (H). Co-immunostaining with TH1 in ventral thalamic area (I), preoptic complex
d TH staining are shown in red. Cce: cerebellar corpus. Ha: habenula. Hv: ventral
nucleus, anterior part. T: thalamus. TeO: tectum opticum. TeV: tectal ventricle.
(K).
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acidic protein) antibodies were applied in double-staining experi-
ments with the MANF antibody. The majority of MANF-positive
cells were HuC/D positive cells in the telencephalon, optic tectum,
diencephalon and rhombencephalon (Fig. 2C–E). However, a few
MANF positive processes showed GFAP positive signals in ventral
thalamic region and around telencephalic ventricle (Fig. 2F–H).
The MANF-positive cells were located close to TH1 positive cells
in preoptic, ventral and dorsal thalamic regions, and only few
MANF-containing cells were found to co-express TH1 (Fig. 2I–K).
MANF double-labeling with zrf-1, HuC/D and TH was also per-
formed on 3-dpf and 5-dpf sagittal sections (Suppl Fig. 1).
The result was in agreement with the adult one. The majority of
MANF-containing cells were HuC/D positive cells rather than glial
cells or TH positive mature neurons from early development to
adulthood in zebraﬁsh brains, indicating that zebraﬁsh MANF
appears to be mainly expressed in the mature neuronal cells.
Splice-blocking MOs perturb MANF expression
To understand the function of MANF during zebraﬁsh devel-
opment, a combination of two antisense splice-blocking MO
(MOsp) were mainly used in this study. The targeting sites of
the two MOs, MOsp1 and MOsp2, are depicted in Fig. 3A. The
efﬁcacy of MOsp was determined by qPCR using 3 dpf ﬁsh and
immunoreactivity was studied in 5 dpf ﬁsh. The qPCR resultFig. 3. Efﬁcacy of splice-blocking morpholino oligonucletides (MO). (A) The zebraﬁsh
The targeting sites of two MOs are in red (MOsp1 and MOsp2). The primer pair used fo
manf MOsp embryos were used to determine the MO efﬁciency. Band 1 in the gel ele
aberrant splicing variants. All PCR products were veriﬁed by sequencing. qPCR was pe
(B) The western blot analysis of MANF expression in the wild type, control MO and ma
control. (C) Bright-ﬁeld images of control, manf MOsp morphants and manf RNA rescue
embryos. A higher magniﬁcation of a posterior neuromast is shown by double-labeling
larvae stained using MANF antibody preabsorbed with MANF blocking peptide to exami
an, anterior neuromast; L, liver; pn, posterior neuromast. Scale bar¼100 mm.showed that the combination of MOsps injection perturbed
approxiamately 75% of normal manf pre-mRNA splicing at 3 dpf
(Fig. 3A). Moreover, the western blot depicted that the MANF
protein was reduced by maximum of 85% following manf MOsps
injection at 3 dpf (Fig. 3B). The immunohistochemistry showed
that MOsp successfully knocked down MANF protein expression
in the brain, skin cells, anterior and posterior neuromasts and
liver at 5 dpf (Fig. 3D). An antigen absorption control was
performed to conﬁrm the speciﬁcity of MANF antibody in zebra-
ﬁsh. The blocking peptide successfully wiped out the immuno-
blotting signal and immunoreactivity (Fig. 3B and D blocking
peptide).
To conﬁrm the speciﬁcity of manf MOsp, qPCR was further
carried out to quantify the mRNA level of p53 and delta 113p53
using 1 dpf embryos (Robu et al., 2007). p53 and delta 113p53,
recognized as off-targeting markers, are induced usually by the
MO knockdown technology resulting in non-speciﬁc morphologi-
cal phenotypes such as a small size of head, neural death and
curved body in MO-injected embryos at 1 dpf. The qPCR result
showed that the mRNA level of p53 was not altered although that
of delta 113p53 was four times higher than in the ctrl MO group
(data not shown). Nonetheless, MANF-deﬁcient morphants devel-
oped with a normal size of head, eyes, somites and notochordwithout
any apparent defects in the head at 24 hpf, or any distinguishable
gross phenotype at 3 dpf (Fig. 3C). Importantly, the phenotypic
changes induced by manf MOsps were rescued by co-injection ofmanf gene includes four exons. The translation start site is located in the exon 1.
r RT-PCR is shown in blue (F1 and F2). Transcripts of 3-dpf uninjected, control and
ctrophoresis indicates the regular manf transcript. Bands 2, 3 and 4 represent the
rformed to quantify the mRNA expression level (*po0.05, n¼3, Student’s t-test).
nf MOsp- injected groups at 3 dpf. The blot of anti-b-actin was used as an internal
larvae at 3 dpf. (D) MANF immunostaining on 5-dpf ctrl MO, manf MOsp injected
with MANF shown in red and acetylated tubulin shown in green. The uninjected
ne the speciﬁcity of MANF antibody. MANF positive cells were labeled in bright red.
Fig. 4. Declines of gene expression of two tyrosine hydroxylases, dopamine transporter and dopamine level inmanfMOsp morphants. Spatial distribution of th1, th2 and datwas
revealed by whole mount in situ hybridization at 3 dpf control MO, manf MOsp andmanf RNA rescued morphants. (A–C) A dorsal view of TH 1 immunohistochemistry. (D–F) A
lateral view of th1 expression pattern. (G–I) A dorsal view of th1 expression pattern. (J–L) A dorsal view of dat expression pattern. (M–O) A dorsal view of th2 expression pattern.
Quantitative analysis of the number of th1-containing cells (P) and dat-positive cells (Q) in prethalanus and TPp dopaminergic populations 5,6,11 and 12 deﬁned by Sallinen et al.,
2009b; DC1 and DC2 group deﬁned by (Rink and Wullimann, 2002; Schweitzer et al., 2012). (R) The percentage of embryos with normal and decreased th2-positive signal
(***po0.001, one-way ANOVA with Dunnett’s test). (S–T) qPCR analysis of th1 and th2 transcript levels (*po0.05, n¼3, Student’s t test). (U) dopamine concentration measured
by HPLC at 4 dpf (**po0.01, n¼4, Student’s t test). The frame shown in the G–L indicates the deﬁciency of th1 cell populations (TH1 populations 5,6,11 and 12) in a manfMOsp
morphant. The arrow in M–O indicates the site of the deﬁciency of th2 cell population in caudal hypothalamus (Hc, group 10b) in amanfMOsp morphant. AAN: arch-associated
neurons; DC: diencephalic catecholaminergic cluster; LC: locus coeruleus; MC: medulla catecholamergic cluster; OB: olfactory bulb. Pr: dorsal pretectum; Sym: sympathetic
neurons; TPp: periventricular nucleus of posterior tuberculum. Scale bar¼100 mm.
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enabled speciﬁc inhibition of MANF expression.
Knockdown of MANF decreases th1, th2 and dat expression
MANF is reported to have neurotrophic effects on the regula-
tion of development of dopaminergic neurons in vitro (Petrova
et al., 2003). Tyrosine hydroxylase (TH) is the rate-limiting
enzyme in the biosynthesis of catecholamines and commonly
used as a dopaminergic neuron marker. In zebraﬁsh, two non-
allelic th genes, th1 and th2, have been reported (Candy and Collet,
2005; Chen et al., 2009; Filippi et al., 2010; Yamamoto et al.,
2010). To investigate whether knocking down MANF expression
has any effects on th1 and th2 expression in vivo, whole mount
in situ hybridization and qPCR were performed on 3 dpf ctrl MO
and MANF MO injected ﬁsh. The number of th1-containing cells in
prethalamus and periventricular nucleus of posterior tuberculum
(TPp), DC1 and DC2 deﬁned in (Rink and Wullimann, 2002;
Schweitzer et al., 2012) and dopaminergic cell group 5,6,11 and
12 in Sallinen et al., 2009b, was decreased in the manf MOsp
injected group compared to the ctrl MO group (Fig. 4D, E, G, H and
P). The expression pattern of the dopamine transporter (dat) in
manf morphants was affected: there were fewer dat-containing
cells in the prethalamus and TPp (Fig. 4J, K, L and R). No obvious
changes were observed in other th1 cell groups in diencephalon
(Suppl Fig. 3). Furthermore, the th2 positive signal in caudal
hypothalamus (Hc, group 10B, deﬁnition based on th2 cell groups
as described earlier by Chen et al., 2009. was reduced in MANF-
deﬁcient morphants compared to that in the ctrl MO group
(Fig. 4M, N and R). At this early stage, the other th2 cell groups
were not sufﬁciently developed to allow reliable evaluation. The
effect was apparently speciﬁc because co-injecting zebraﬁsh manf
mRNA with antisense manf MOsp was able to rescue the decrease
of th1, dat and th2 cell groups at 3 dpf (Fig. 4F, I, L and O). qPCR
results also conﬁrmed that th1 and th2 transcript levels were
signiﬁcantly lower in the MANF knockdown group than in the
control and manf mRNA rescue groups (Fig. 4S and T). Immuno-
cytochemistry using TH1 antibody on 3 dpf MANF deﬁcient ﬁsh
revealed the same defect as that shown by in situ hybridization
(Fig. 4A and B). Moreover, manf mRNA injection rescued the
decrease of the TH1-containing cells (Fig. 4C). Importantly, the
dopamine level was signiﬁcantly decreased in MANF morphants
(Fig. 4U), and the decrease of dopamine level was restored by
manf mRNA injection. During early development, the number of
th1-containing cells was lower than control and manf rescue
groups at 24 hpf and 36 hpf (Suppl Fig. 2). Over-expression of
manfmRNA at early embryonic stages did not affect dopaminergic
neuron development (Suppl Fig. 2). Taken together, lack of MANF
resulted in a signiﬁcant decrease of th1, dat and th2-containing
cells in the prethalamus and TPp region, suggesting that MANF
may play an important role in regulation of the dopaminergic
neuron development during zebraﬁsh embryonic development.
Knockdown of manf does not alter 5-HT, GABA and epinephrine levels
or hdc and hcrt expression
To demonstrate that manf MOsp does not exhibit a general
effect on all hypothalamic neuron populations, the serotonergic
and GABAergic systems were analyzed by 5-HT and GABA
immunostaining because 5-HT and GABA synthesis is mediated
by proteins encoded by several genes, the histaminergic system
by hdc mRNA level (the diagnostic marker of hypothalamic
histaminergic neurons) and hypocretin/orexin system by hcrt
mRNA level (hypocretin neuropeptide precursor) were quantiﬁed
by qPCR because these transmitters are produced by proteins
encoded by single genes. The expression pattern of 5-HT andGABA immunoreactivity on 5 dpf brains was not altered in MANF
morphants (Fig. 5A–D). In addition, the serotonin and epinephrine
levels measured by HPLC (Fig. 5E and F) and hdc and hcrt
expression did not differ in 3 dpf MANF morphants from that
of control MO treated ﬁsh (Fig. 5G, H; p40.05, n¼3 Student’s
t-test). These data indicated that MANF is at least to a signiﬁcant
degree speciﬁcally involved in regulation of dopaminergic neuron
development.
The expression patterns of Notch1a, zash1a and BrdU labeled cells are
not altered
Lack of MANF in embryonic stages caused a signiﬁcant
decrease of catecholaminergic neurons in group 5,6,11 and 12 of
th1 clusters located in the prethalamus and TPp and group 10b of
th2 cells in the caudal hypothalamus. Since MANF was mostly
expressed in HuC/D positive cells, we hypothesized that MANF
may have function on regulation of differentiation and matura-
tion of dopaminergic neurons during development. In order to
examine this hypothesis, several zebraﬁsh genes involved in early
neurogenesis were ﬁrst analyzed (Mueller and Wullimann, 2002,
2003; Wullimann and Mueller, 2002). In situ hybridization was
performed on 2 dpf ﬁsh using Notch1a (a proliferative cell marker,
Fig. 6A–C) and zash1a (a proneural marker, Fig. 6D–F). The BrdU
saturation labeling was performed to detect all proliferative cells
at 5 dpf (Fig. 6G–I). In comparison with those of the control group,
the signals in MANF morphant groups showed no difference,
suggesting that MANF may not be involved in the early prolifera-
tion phase but possibly in the later differentiation and maturation
stage or in the maintained survival of the progenitor neuron cells
in the dopaminergic neuronal lineage.
Increase of nr4a2b and pax2a transcripts in manf MOsp
morphants at 3 dpf
pax2 and pax5 are reported to be involved in the differentiation
of dopaminergic progenitors, and Nr4a2 plays an important role
in both the survival and differentiation of mesencephalic dopa-
minergic precursor cells (Blin et al., 2008; Luo et al., 2008; Simon
et al., 2003). To conﬁrm our hypothesis that MANF may partici-
pate in later differentiation of the dopaminergic development,
zebraﬁsh Nr4a2b, pax2a and pax5 were studied in 3-dpf larvae.
Compared to the control group, manf-deﬁcient larvae showed an
increase of nr4a2b positive signals in the posterior tuberculum
(15 individuals out of 15, white rectangle in Fig. 7A and B),
rhombencenphalic area (white arrow in Fig. 7A and B) and spinal
cord (Fig. 7D and E). The pax2a transcript was also increased in
midbrain hindbrain boundary, hindbrain (15 individuals out of
15, Fig. 7G and H) and spinal cord (Fig. 7J and K) in manf-deﬁcient
larvae compared to that of the control group. Zebraﬁsh manf
mRNA co-injected with the manf MOs prevented the increase of
nr4a2a expression in the posterior tuberculum and spinal cord as
well as pax2a expression in rhobencephalic and spinal cord in
manf morphants (Fig. 7C, F, I and L). The in situ hybridization
result was further validated by qPCR. The transcript level of
nr4a2b in manf morphants showed a tendency towards increase
compared to ctrl MO andmanfmRNA co-injected groups although
the increase of nr4a2b was not statistically signiﬁcant (Fig. 7M;
p40.05, n¼3, Student’s t-test). It is possible that the highly
localized increase is not evident in qPCR done on whole embryos
due to expression in many other sites. The pax2a qPCR analysis
result, a signiﬁcant increase (po0.05, n¼3, Student’s t-test), was
in accordance with the in situ hybridization result. The pax5
transcript level showed no difference between control, manf
morphants and manf mRNA co-injected groups (Fig. 7O). In short,
knockdown of MANF resulted in up regulation of nr4a2b and
Fig. 5. Knockdown ofmanf did not alter the serotonergic system, GABAergic system, hdc and hcrt expression inmanf deﬁcient embryos. (A and B) 5-HT and (C and D) GABA
immunostainingin control MO and manf MOsp morphants in 5 dpf brains. (E) The serotonin level and (F) the epinephrine level measured by HPLC. qPCR analysis of hdc
(G) and hcrt (H) transcript levels in 3 dpf larvae (p40.05, n¼3, Student’s t-test). Scale bar¼100 mm.
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impairment, suggesting that MANF may interact with Nr4a2
and pax2a in regulation of the differentiation of dopaminergic
development.
MANF partially rescues the decrease of th1 containing cells in Nr4a2
morphants
Two homologs of mammalian nr4a2 genes, nr4a2a and nr4a2b,
are found in zebraﬁsh (Blin et al., 2008; Filippi et al., 2007;
Luo et al., 2008). Both nr4a2 genes play an important role in
regulation of differentiation of dopaminergic neurons in the poster-
ior tuberculum region in developing zebraﬁsh brain (Blin et al.,
2008; Luo et al., 2008). Knocking down both nr4a2 expression wasassociated with a signiﬁcant decrease of th1 positive cells in
amacrine neurons, preoptic area, prethalamus, and the posterior
tuberculum region in Nr4a2 morphants (Fig. 8A and B). This th1
defect in the Nr4a2 morphants in this study was in agreement to
the ﬁndings of Blin et al., 2008 and Luo et al., 2008. A similar
decline in th1 expressing neurons was evident also in the manf-
deﬁcient larvae in the present study in the prethalamus and TPp
(population 5,6,11 and 12) (Fig. 4G–I). We hypothesized that
MANF and Nr4a2 may regulate dopaminergic development in the
same pathway in certain brain areas. To test this hypothesis, manf
mRNA was overexpressed in the Nr4a2 morphants. Strikingly, the
th1 in situ hybridization and qPCR analysis showed that manf
mRNA prevented the decrease of th1 expression in selective
diencephalic regions, population 5,6,11 and 12 (white rectangle,
Fig. 6. Expression pattern of Notch1a, zash1a and BrdU labeled cells did not alter. Spatial distribution of Notch1a and zash1a was revealed by whole mount in situ
hybridization at 2 dpf control MO, manf MOsp and manf RNA rescued morphants. BrdU saturation label analysis was performed in 5 dpf ﬁsh. (A–C) The dorsal view of
Notch1a expression pattern. (D–F) The dorsal view of zash1a expression pattern. (G–I) The dorsal view of BrdU labeled cells. Scale bar¼100 mm.
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On the other hand, the expression level of th2 was signiﬁcantly
reduced in Nr4a2 morphants compared to the ctrl MO group
whereas manf mRNA could not restore the decreased level of th2
transcripts in Nr4a2 morphants (Fig. 8F). manf transcript level
showed a tendency towards a decline in Nr4a2 morphants
compared to that of the control group (Fig. 8G; p¼0.06, n¼3,
Student’s t-test).Discussion
In this report, we speciﬁcally abolished MANF expression by
means of antisense morpholino oligonucleotides in zebraﬁsh. The
knockdown effect was veriﬁed using a speciﬁc antibody against
MANF, and sequencing of the aberrant transcripts. The effect
appeared to be speciﬁc, because no characteristic abnormal
morphological phenotype was shown, and co-injection of manf
mRNA withmanfMOsp rescued the defects observed. Despite this
apparent lack of gross phenotype, the knockdown of MANF
caused a decrease of catecholaminergic neurons in the certain
diencephalic region and led to a signiﬁcant decrease of dopamine
during zebraﬁsh embryonic development. Remarkably, manf
mRNA enabled a rescue of the decrease of th1 positive cells in
the diencephalon in the Nr4a2 deﬁcient larvae. These results
reveal for the ﬁrst time in a vertebrate model that MANF interacts
with Nr4a2 and plays a crucial role in regulation of dopaminergic
neuron development and maintenance.
MANF distribution in ﬂy and rodents has been characterized
(Lindholm et al., 2008; Palgi et al., 2009). It is widely expressed in
central nervous system and in peripheral organs at all develop-
ment stages and in adult animals. In the fruitﬂy, it is detectable in
glial cells, but not co-localized with any known neuronal markers.
In mammalian brains, it is largely expressed in cells with
neuronal morphology, and a few MANF positive dopaminergicneurons can be found in substantia nigra pars compacta (Lindholm
et al., 2008). Likewise, zebraﬁsh MANF has widespread expression at
various stages in the central nervous system and peripheral organs.
Before the gastrula stage manf mRNA is distributed in the axis
notochord, ﬂoor plate and hatching gland. Moreover, zebraﬁsh manf
RNA has the highest expression during pharyngula stage, but the
expression declines in the brain at later stages. Both in mice and
zebraﬁsh, manf mRNA was detected at early embryogenesis and
expressed in brain and peripheral organs. Based on the high
similarity of spatiotemporal distribution and predicted protein
structures across the species, MANF may play a role during devel-
opmental stages. In adult zebraﬁsh brain, the main expression
regions are largely restricted in ventricular zones along the entire
anteroposterior axis. These regions have been deﬁned as prolifera-
tion zones that include neural stem cells involved in neurogenesis in
zebraﬁsh brain (Grandel et al., 2006; Kaslin et al., 2008). Interest-
ingly, most MANF-positive cells are Hu/D positive cells surrounding
TH-positive cells indeed but lack GFAP expression, suggesting that
MANF is expressed in neuronal rather than glial cells in zebraﬁsh
brain, a clear difference from the expression pattern in ﬂy. These
results illustrate that zebraﬁsh MANF is mostly expressed in the
neuronal cells, and provide useful evidence that MANF plays a
crucial role in maintenance or regulation of dopaminergic, but not
e.g. histaminergic, hypocretin/orexin, or GABAergic neurons in
central nervous system.
The MO knockdown technique provides a powerful tool to
temporally knockdown gene expression in zebraﬁsh. Although
MOs may cause some unexpected side effects, under appropriate
controls such as mRNA rescue experiments and p53 diagnosis of
off-targeting effect, it enables speciﬁc and effective knockdown of
genes of interest (Eisen and Smith, 2008; Robu et al., 2007). In this
study, two types of MOs against MANF expression were applied, a
translation-blocking MO disturbing the translation mechanism of
maternal and zygotic mRNA (data not shown) and a splice-
blocking MO perturbing the zygotic pre-RNA splicing process.
Fig. 7. Increase of nr4a2b and pax2a expression in manf MOsp morphants at 3 dpf. The spatial distribution of nr4a2b and pax2a was revealed by whole mount in situ
hybridization. (A–C) dorsal views of nr4a2b expression pattern in the head and (D–F) lateral views of the spinal cord. (G–H) dorsal views of pax2a expression pattern in the
head and (J–L) lateral views of the spinal cord. qPCR analysis of nr4a2b (M), pax2a (N) and pax5(O) (*po0.05, n¼3, Student’s t-test). White rectangles indicate the increase
of nr4a2b expression in the posterior tuberculum and white arrows indicate the increased nr4a2b and pax2a expression in rhombencephalon in manf MOsp morphants.
Scale bar¼100 mm.
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the speciﬁcity of the working manf MOs. The MANF-deﬁcient ﬁsh
had no apparent phenotypic defects within 5 dpf and morphant
larvae swam normally (data not shown) although shortage of
MANF caused a reduction of tyrosine hydroxylase positive cells
during embryogenesis. This phenotype, however, is contradictory
to the MANF mutant ﬂy (Palgi et al., 2009). In Drosophila, lack of
MANF has a lethal effect, characterized by a massive degeneration
of cells, disappearance of axon bundles, and developmental
abnormalities of the nervous system and cuticular elements.
Nevertheless, both MANF deﬁcient animal models are character-
ized by the decrease of dopamine and dopamine neurons. The
different outcomes may be due to signiﬁcant differences in the
organization of neurotransmitter systems between invertebrates
and vertebrates, even if MANF is an evolutionarily conserved
neurotrophic factor. Interestingly, the species-related phenotype
differences among human, zebraﬁsh and fruitﬂy also appear in
some other PD-related genes such as parkin and pink1 (Botella
et al., 2009; Flinn et al., 2009; Kitada et al., 2007; Park et al., 2006;
Pienaar et al., 2010; Sallinen et al., 2010). In those cases, themutant zebraﬁsh share more phenotypic identities with primates
compared to those invertebrate models (Pienaar et al., 2010).
On the other hand, MOs work effectively only within the ﬁrst few
days of ﬁsh life because of dilution during embryogenesis, so that
the phenotype difference may be in part due to the incomplete
perturbation. Further studies using a stable MANF mutant zebra-
ﬁsh line, when one becomes available, may provide a solution to
conﬁrm the phenotype observed in this study.
Due to the gene duplication in the vertebrate lineage, there are
two th genes in zebraﬁsh, th1 and th2 (Candy and Collet, 2005;
Chen et al., 2009; Filippi et al., 2010; Yamamoto et al., 2010).
Since zebraﬁsh has evolved as a signiﬁcant model animal for
studying human neurodegenerative diseases, it is important to
understand the difference of catecholamine system between
zebraﬁsh and mammals (Panula et al., 2010; Schweitzer and
Driever, 2009). Studies of th1 have been carried out for a long
time (Kaslin and Panula, 2001; Ma, 1997; Panula et al., 2010;
Rink and Wullimann, 2001; Schweitzer and Driever, 2009) while
the th2 expression pattern in larval zebraﬁsh was ﬁrst revealed by
Chen et al., 2009, yet the biological function of th2 is still unclear.
Fig. 8. MANF partially rescued the loss of th1 cells in 3 dpf Nr4a2 morphants. (A–C) th1 expression pattern was revealed by whole mount in situ hybridization at 3 dpf
control MO, Nr4a2 MO and Nr4a2 MO co-injected with manf mRNA embryos, anterior to the left and dorsal to the top. (D) Quantitative analysis of the number of
th1-containing cells in prethalanus and TPp dopaminergic population 5,6,11 and 12 deﬁned by Sallinen et al., 2009b; DC1 and DC2 group deﬁned by Rink and Wullimann,
2002. (***po0.001, one-way ANOVA with Dunnett’s test) (E and F) qPCR analysis of th1, th2 and manf transcript levels (*po0.05, n¼3, Student’s t test). White rectangles
indicate the loss of th1 cell population in population 5,6,11 and 12. TPp: periventricular nucleus of posterior tuberculum. Scale bar¼100 mm.
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tion of both th1 and th2 in the diencephalic groups 5,6,11 and 10b
(see Sallinen et al., 2009b and Chen et al., 2009) during embry-
ogenesis, suggesting that MANF may be involved in regulation of
the development of both th1 and th2 containing neurons, but not
GABAergic, serotonergic or histaminergic neurons which also
reside in caudal hypothalamus close to the th2 cell group 10b.
MANF is largely expressed in postmitotic neuronal cells in
proliferation zones in zebraﬁsh brains. Since the expression
pattern of several proliferation markers shows no change in
MANF deﬁcient embryos, it is possible that MANF is involved in
differentiation of the dopaminergic progenitors into mature
dopaminergic neurons.
A number of regulators and neurotrophic factors have been
identiﬁed to control or maintain the developmental fate of dopami-
nergic neurons (Andressoo and Saarma, 2008). For instance, tran-
scription factors pax2/5 participate in the late proliferation of
dopaminergic progenitor cells (Simon et al., 2003). The orphan
steroid receptor Nr4a2 is essential in differentiation of dopami-
nergic precursor cells and maintenance of dopamine neurons
(Jankovic et al., 2005; Kadkhodaei et al., 2009). Loss of Nr4a2
leads to a decline of certain dopaminergic populations. On the
other hand, it is possible that overexpression of Nr4a2 could cause
the impairments of differentiation and maturation of dopaminer-
gic cells. In manf-deﬁcient larvae, a higher expression level of
pax2a and nr4a2b transcripts was observed while this up-
regulation was prevented by manf mRNA overexpression, indicat-
ing that MANF may have an inhibitory effect on nr4a2 and pax2a
to direct dopaminergic precursors differentiating into mature
dopamine neurons. Moreover, in Nr4a2 morphants, manf mRNA
enabled a rescue of the decrease of th1 expression in the
prethalamus and TPp area, indicating that MANF may compensate
the loss of Nr4a2 in order to maintain the regular development of
dopaminergic neurons. That MANF and Nr4a2 function in the
same pathway to regulate the dopaminergic development in
particular regions of the zebraﬁsh brain is possible. It is still
unclear whether MANF and Nr4a2 regulate dopaminergic neuron
development in the same mechanism or compensate each other.
However, this study provides direct in vivo evidence that MANF is
a relatively speciﬁc neurotrophic factor that is required for thedevelopment, differentiation or maintenance of dopamine neu-
rons in embryogenesis.
In summary, this work indicates that zebraﬁsh MANF is
involved in regulating the development of certain groups of
dopaminergic neurons in developing brains, and enables to rescue
the loss of dopamine neurons in Nr4a2-diﬁcient ﬁsh. Our MANF-
deﬁcient ﬁsh may provide a good animal model to study how
MANF and other factors regulate the development and protection
of dopaminergic system.Acknowledgments
Supported by the Academy of Finland and Sigrid Juselius
Foundation.Appendix A. Supporting information
Supplementary data associated with this article can be found in
the online version at http://dx.doi.org/10.1016/j.ydbio.2012.07.030.References
Airavaara, M., Shen, H., Kuo, C.C., Peranen, J., Saarma, M., Hoffer, B., Wang, Y., 2009.
Mesencephalic astrocyte-derived neurotrophic factor reduces ischemic brain
injury and promotes behavioral recovery in rats. J. Comp. Neurol. 515,
116–124.
Andressoo, J.O., Saarma, M., 2008. Signalling mechanisms underlying development
and maintenance of dopamine neurons. Curr. Opin. Neurobiol. 18, 297–306.
Bandmann, O., Burton, E.A., 2010. Genetic zebraﬁsh models of neurodegenerative
diseases. Neurobiol. Dis. 40, 58–65.
Blin, M., Norton, W., Bally-Cuif, L., Vernier, P., 2008. NR4A2 controls the differ-
entiation of selective dopaminergic nuclei in the zebraﬁsh brain. Mol. Cell.
Neurosci. 39, 592–604.
Botella, J.A., Bayersdorfer, F., Gmeiner, F., Schneuwly, S., 2009. Modelling
Parkinson’s disease in drosophila. Neuromol. Med. 11, 268–280.
Candy, J., Collet, C., 2005. Two tyrosine hydroxylase genes in teleosts. Biochim.
Biophys. Acta 1727, 35–44.
Chen, Y.C., Priyadarshini, M., Panula, P., 2009. Complementary developmental
expression of the two tyrosine hydroxylase transcripts in zebraﬁsh. Histo-
chem. Cell Biol. 132, 375–381.
Y.-C. Chen et al. / Developmental Biology 370 (2012) 237–249 249Dauer, W., Przedborski, S., 2003. Parkinson’s disease: mechanisms and models.
Neuron 39, 889–909.
Eisen, J.S., Smith, J.C., 2008. Controlling morpholino experiments: don’t stop
making antisense. Development 135, 1735–1743.
Filippi, A., Durr, K., Ryu, S., Willaredt, M., Holzschuh, J., Driever, W., 2007.
Expression and function of nr4a2, lmx1b, and pitx3 in zebraﬁsh dopaminergic
and noradrenergic neuronal development. BMC Dev. Biol. 7, 135.
Filippi, A., Mahler, J., Schweitzer, J., Driever, W., 2010. Expression of the paralogous
tyrosine hydroxylase encoding genes th1 and th2 reveals the full complement
of dopaminergic and noradrenergic neurons in zebraﬁsh larval and juvenile
brain. J. Comp. Neurol. 518, 423–438.
Fink, M., Flekna, G., Ludwig, A., Heimbucher, T., Czerny, T., 2006. Improved
translation efﬁciency of injected mRNA during early embryonic development.
Dev. Dyn. 235, 3370–3378, An ofﬁcial publication of the American Association
of Anatomists.
Flinn, L., Mortiboys, H., Volkmann, K., Koster, R.W., Ingham, P.W., Bandmann, O.,
2009. Complex I deﬁciency and dopaminergic neuronal cell loss in parkin-
deﬁcient zebraﬁsh (Danio rerio). Brain: A Journal of Neurology 132,
1613–1623.
Grandel, H., Kaslin, J., Ganz, J., Wenzel, I., Brand, M., 2006. Neural stem cells and
neurogenesis in the adult zebraﬁsh brain: origin, proliferation dynamics,
migration and cell fate. Dev. Biol. 295, 263–277.
Hellman, M., Arumae, U., Yu, L.Y., Lindholm, P., Peranen, J., Saarma, M., Permi, P.,
2011. Mesencephalic astrocyte-derived neurotrophic factor (MANF) has a
unique mechanism to rescue apoptotic neurons. J. Biol. Chem. 286,
2675–2680.
Hellman, M., Peranen, J., Saarma, M., Permi, P., 2010. 1H, 13C and 15N resonance
assignments of the human mesencephalic astrocyte-derived neurotrophic
factor. Biomol. NMR Assignments 4, 215–217.
Hoseki, J., Sasakawa, H., Yamaguchi, Y., Maeda, M., Kubota, H., Kato, K., Nagata, K.,
2010. Solution structure and dynamics of mouse ARMET. FEBS Lett. 584,
1536–1542.
Jankovic, J., Chen, S., Le, W.D., 2005. The role of Nurr1 in the development of
dopaminergic neurons and Parkinson’s disease. Prog. Neurobiol. 77, 128–138.
Kadkhodaei, B., Ito, T., Joodmardi, E., Mattsson, B., Rouillard, C., Carta, M.,
Muramatsu, S., Sumi-Ichinose, C., Nomura, T., Metzger, D., Chambon, P.,
Lindqvist, E., Larsson, N.G., Olson, L., Bjorklund, A., Ichinose, H., Perlmann, T.,
2009. Nurr1 is required for maintenance of maturing and adult midbrain
dopamine neurons. J. Neurosci. 29, 15923–15932, The ofﬁcial journal of the
Society for Neuroscience.
Karhunen, T., Airaksinen, M.S., Tuomisto, L., Panula, P., 1993. Neurotransmitters in
the nervous system of Macoma balthica (Bivalvia). J. Comp. Neurol. 334,
477–488.
Kaslin, J., Ganz, J., Brand, M., 2008. Proliferation, neurogenesis and regeneration in
the non-mammalian vertebrate brain. Philos. Trans. R. Soc. London, Ser. B 363,
101–122.
Kaslin, J., Nystedt, J.M., Ostergard, M., Peitsaro, N., Panula, P., 2004. The orexin/
hypocretin system in zebraﬁsh is connected to the aminergic and cholinergic
systems. J. Neurosci. 24, 2678–2689, The ofﬁcial journal of the Society for
Neuroscience.
Kaslin, J., Panula, P., 2001. Comparative anatomy of the histaminergic and other
aminergic systems in zebraﬁsh (Danio rerio). J. Comp. Neurol. 440, 342–377.
Kelley, L.A., Sternberg, M.J., 2009. Protein structure prediction on the web: a case
study using the phyre server. Nat. Protoc. 4, 363–371.
Kim, C.H., Ueshima, E., Muraoka, O., Tanaka, H., Yeo, S.Y., Huh, T.L., Miki, N., 1996.
Zebraﬁsh elav/HuC homologue as a very early neuronal marker. Neurosci. Lett.
216, 109–112.
Kimmel, C.B., Ballard, W.W., Kimmel, S.R., Ullmann, B., Schilling, T.F., 1995. Stages
of embryonic development of the zebraﬁsh. Dev. Dyn. 203, 253–310, An
ofﬁcial publication of the American Association of Anatomists.
Kitada, T., Pisani, A., Porter, D.R., Yamaguchi, H., Tscherter, A., Martella, G., Bonsi, P.,
Zhang, C., Pothos, E.N., Shen, J., 2007. Impaired dopamine release and synaptic
plasticity in the striatum of PINK1-deﬁcient mice. PNAS 104, 11441–11446.
Lin, C., Spikings, E., Zhang, T., Rawson, D.M., 2009. Effect of chilling and
cryopreservation on expression of Pax genes in zebraﬁsh (Danio rerio) embryos
and blastomeres. Cryobiology 59, 42–47.
Lindholm, P., Peranen, J., Andressoo, J.O., Kalkkinen, N., Kokaia, Z., Lindvall, O.,
Timmusk, T., Saarma, M., 2008. MANF is widely expressed in mammalian
tissues and differently regulated after ischemic and epileptic insults in rodent
brain. Mol. Cell. Neurosci. 39, 356–371.
Lindholm, P., Saarma, M., 2010. Novel CDNF/MANF family of neurotrophic factors.
Dev. Neurobiol. 70, 360–371.
Lindholm, P., Voutilainen, M.H., Lauren, J., Peranen, J., Leppanen, V.M., Andressoo,
J.O., Lindahl, M., Janhunen, S., Kalkkinen, N., Timmusk, T., Tuominen, R.K.,
Saarma, M., 2007. Novel neurotrophic factor CDNF protects and rescues
midbrain dopamine neurons in vivo. Nature 448, 73–77.
Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using
real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25,
402–408.
Luo, G.R., Chen, Y., Li, X.P., Liu, T.X., Le, W.D., 2008. Nr4a2 is essential for the
differentiation of dopaminergic neurons during zebraﬁsh embryogenesis. Mol.
Cell. Neurosci. 39, 202–210.Ma, P.M., 1997. Catecholaminergic systems in the zebraﬁsh. III. Organization and
projection pattern of medullary dopaminergic and noradrenergic neurons.
J. Comp. Neurol. 381, 411–427.
Mueller, T., Wullimann, M.F., 2002. BrdU-, neuroD (nrd)- and Hu-studies reveal
unusual non-ventricular neurogenesis in the postembryonic zebraﬁsh fore-
brain. Mech Dev. 117, 123–135.
Mueller, T., Wullimann, M.F., 2003. Anatomy of neurogenesis in the early zebraﬁsh
brain. Dev. Brain Res. 140, 137–155.
Palgi, M., Lindstrom, R., Peranen, J., Piepponen, T.P., Saarma, M., Heino, T.I., 2009.
Evidence that DmMANF is an invertebrate neurotrophic factor supporting
dopaminergic neurons. PNAS 106, 2429–2434.
Panula, P., Chen, Y.C., Priyadarshini, M., Kudo, H., Semenova, S., Sundvik, M.,
Sallinen, V., 2010. The comparative neuroanatomy and neurochemistry of
zebraﬁsh CNS systems of relevance to human neuropsychiatric diseases.
Neurobiol. Dis. 40, 46–57.
Park, J., Lee, S.B., Lee, S., Kim, Y., Song, S., Kim, S., Bae, E., Kim, J., Shong, M., Kim,
J.M., Chung, J., 2006. Mitochondrial dysfunction in drosophila PINK1 mutants
is complemented by parkin. Nature 441, 1157–1161.
Parkash, V., Lindholm, P., Peranen, J., Kalkkinen, N., Oksanen, E., Saarma, M.,
Leppanen, V.M., Goldman, A., 2009. The structure of the conserved neuro-
trophic factors MANF and CDNF explains why they are bifunctional. PEDS 22,
233–241.
Petrova, P., Raibekas, A., Pevsner, J., Vigo, N., Anaﬁ, M., Moore, M.K., Peaire, A.E.,
Shridhar, V., Smith, D.I., Kelly, J., Durocher, Y., Commissiong, J.W., 2003. MANF:
a new mesencephalic, astrocyte-derived neurotrophic factor with selectivity
for dopaminergic neurons. J. Mol. Neurosci. 20, 173–188.
Petrova, P.S., Raibekas, A., Pevsner, J., Vigo, N., Anaﬁ, M., Moore, M.K., Peaire, A.,
Shridhar, V., Smith, D.I., Kelly, J., Durocher, Y., Commissiong, J.W., 2004.
Discovering novel phenotype-selective neurotrophic factors to treat neurode-
generative diseases. Prog. Brain Res. 146, 168–183.
Pienaar, I.S., Gotz, J., Feany, M.B., 2010. Parkinson’s disease: insights from non-
traditional model organisms. Prog. Neurobiol. 92, 558–571.
Rink, E., Wullimann, M.F., 2001. The teleostean (zebraﬁsh) dopaminergic system
ascending to the subpallium (striatum) is located in the basal diencephalon
(posterior tuberculum). Brain Res. 889, 316–330.
Rink, E., Wullimann, M.F., 2002. Development of the catecholaminergic system in
the early zebraﬁsh brain: an immunohistochemical study. Dev. Brain Res. 137,
89–100.
Robu, M.E., Larson, J.D., Nasevicius, A., Beiraghi, S., Brenner, C., Farber, S.A., Ekker,
S.C., 2007. p53 activation by knockdown technologies. PLoS Genet. 3, e78.
Sallinen, V., Kolehmainen, J., Priyadarshini, M., Toleikyte, G., Chen, Y.C., Panula, P.,
2010. Dopaminergic cell damage and vulnerability to MPTP in Pink1 knock-
down zebraﬁsh. Neurobiol. Dis. 40, 93–101.
Sallinen, V., Sundvik, M., Reenila, I., Peitsaro, N., Khrustalyov, D., Anichtchik, O.,
Toleikyte, G., Kaslin, J., Panula, P., 2009a. Hyperserotonergic phenotype after
monoamine oxidase inhibition in larval zebraﬁsh. J. Neurochem. 109,
403–415.
Sallinen, V., Torkko, V., Sundvik, M., Reenila, I., Khrustalyov, D., Kaslin, J., Panula, P.,
2009b. MPTP and MPPþ target speciﬁc aminergic cell populations in larval
zebraﬁsh. J. Neurochem. 108, 719–731.
Schweitzer, J., Driever, W., 2009. Development of the dopamine systems in
zebraﬁsh. Adv. Exp. Med. Biol. 651, 1–14.
Schweitzer, J., Lohr, H., Filippi, A., Driever, W., 2012. Dopaminergic and noradre-
nergic circuit development in zebraﬁsh. Dev. Neurobiol. 72, 256–268.
Simon, H.H., Bhatt, L., Gherbassi, D., Sgado, P., Alberi, L., 2003. Midbrain dopami-
nergic neurons: determination of their developmental fate by transcription
factors. Ann. N.Y. Acad. Sci. 991, 36–47.
Thisse, C., Thisse, B., 2008. High-resolution in situ hybridization to whole-mount
zebraﬁsh embryos. Nat. Protoc. 3, 59–69.
Voutilainen, M.H., Back, S., Porsti, E., Toppinen, L., Lindgren, L., Lindholm, P.,
Peranen, J., Saarma, M., Tuominen, R.K., 2009. Mesencephalic astrocyte-
derived neurotrophic factor is neurorestorative in rat model of Parkinson’s
disease. J Neurosci. 29, 9651–9659, The Ofﬁcial Journal of the Society for
Neuroscience.
Westerﬁeld, M., 2000. The Zebraﬁsh Book: A Guide for the Laboratory use of
Zebraﬁsh (Danio rerio). M. Westerﬁeld, Eugene, OR.
Wullimann, M.F., Mueller, T., 2002. Expression of Zash-1a in the postembryonic
zebraﬁsh brain allows comparison to mouse mash1 domains. Gene Expression
Patterns 1, 187–192.
Yamamoto, K., Ruuskanen, J.O., Wullimann, M.F., Vernier, P., 2010. Two tyrosine
hydroxylase genes in vertebrates new dopaminergic territories revealed in the
zebraﬁsh brain. Mol. Cell. Neurosci. 43, 394–402.
Yasuda, T., Mochizuki, H., 2010. Use of growth factors for the treatment of
Parkinson’s disease. Exp. Rev. Neurother. 10, 915–924.
Yu, Y.Q., Liu, L.C., Wang, F.C., Liang, Y., Cha, D.Q., Zhang, J.J., Shen, Y.J., Wang, H.P.,
Fang, S., Shen, Y.X., 2010. Induction proﬁle of MANF/ARMET by cerebral
ischemia and its implication for neuron protection. J. Cerebral Blood Flow
Metab. 30, 79–91, Ofﬁcial Journal of the International Society of Cerebral Blood
Flow and Metabolism.
